Titre:
  • Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
Auteur:Michiels, Stefan; Pugliano, Lina; Marguet, Sophie; Grun, D.; Barinoff, Jana; Cameron, Melody; Cobleigh, Angelo; Di Leo, Stephen Rd D S.; Johnston, Giampietro; Gasparini, Bella; Kaufman, Michel; Marty, Valentina; Nekljudova, Shani; Paluch-Shimon, Frederique; Pénault-Llorca, Dennis; Slamon, Charles; Vogel, Gunter; Von Minckwitz, Marc; Buyse, Martine; Piccart-Gebhart,
Informations sur la publication:Annals of oncology, 27, 6, page (1029-1034), mdw132
Statut de publication:Publié, 2016-06
Sujet CREF:Hématologie
Cancérologie
Mots-clés:HER2
Lapatinib
Metastatic breast cancer
Progression-free survival
Surrogate
Trastuzumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdw132
info:scp/84974806641